Literature DB >> 12409892

Physeal fractures, part I: histologic features of bone, cartilage, and bar formation in a small animal model.

J Michael Wattenbarger1, Helen E Gruber, Laura S Phieffer.   

Abstract

Physeal fractures and the formation of physeal bars can pose significant problems in skeletal development for the injured, growing child. Regrettably, little experimental attention has been directed toward this clinical disturbance. The current study documents early histologic changes (days 2-6) and subsequent alterations (day 21) following a physeal fracture in the rat proximal tibia model. The fracture plane was usually contained within the physis but could involve many regions of the physis. In some instances, the fracture plane extended to the physeal epiphyseal border. When the fracture was contained within the physis, healing was uneventful. However, when the fracture extended through the physis to the epiphyseal physeal border, there was greater physeal disorganization and formation of vertical septa leading to physeal bars. Physeal bars appeared to form at sites of vertical fibrotic septa into which marrow cells, osteoclasts, and osteoblasts had migrated. Bar formation mediated by primary osteogenesis (rather than by endochondral bone formation) followed. This study examines the changes in the histologic features of the rat proximal tibial physis, epiphysis, and metaphysis after a physeal fracture and identifies key factors associated with physeal bar formation.

Entities:  

Mesh:

Year:  2002        PMID: 12409892

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  9 in total

1.  Behaviour of human physeal chondro-progenitorcells in early growth plate injury response in vitro.

Authors:  Karin Pichler; Barbara Schmidt; Eva E Fischerauer; Beate Rinner; Gottfried Dohr; Andreas Leithner; Annelie M Weinberg
Journal:  Int Orthop       Date:  2012-05-25       Impact factor: 3.075

2.  [Growth behavior after epiphyseal plate injury: importance of "watertight" osteosynthesis].

Authors:  L von Laer
Journal:  Unfallchirurg       Date:  2014-12       Impact factor: 1.000

3.  Salter Harris Fracture Type II.

Authors:  Trilok Stead; Alice Bai; Shreya Rajachandran; Jesse Glueck; Andrew Barbera
Journal:  Orthop Rev (Pavia)       Date:  2022-03-06

4.  Spatial periodicity in growth plate shear mechanical properties is disrupted by vitamin D deficiency.

Authors:  Derin Sevenler; Mark R Buckley; Grace Kim; Marjolein C H van der Meulen; Itai Cohen; Lawrence J Bonassar
Journal:  J Biomech       Date:  2013-05-21       Impact factor: 2.712

5.  Preclinical studies on mesenchymal stem cell-based therapy for growth plate cartilage injury repair.

Authors:  Rosa Chung; Bruce K Foster; Cory J Xian
Journal:  Stem Cells Int       Date:  2011-07-26       Impact factor: 5.443

6.  Hypertrophic chondrocytes in the rabbit growth plate can proliferate and differentiate into osteogenic cells when capillary invasion is interposed by a membrane filter.

Authors:  Tetsuya Enishi; Kiminori Yukata; Mitsuhiko Takahashi; Ryosuke Sato; Koichi Sairyo; Natsuo Yasui
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

7.  Post-traumatic caspase-3 expression in the adjacent areas of growth plate injury site: a morphological study.

Authors:  Giuseppe Musumeci; Paola Castrogiovanni; Carla Loreto; Sergio Castorina; Karin Pichler; Annelie Martina Weinberg
Journal:  Int J Mol Sci       Date:  2013-07-29       Impact factor: 5.923

8.  Treating Proximal Tibial Growth Plate Injuries Using Poly(Lactic-co-Glycolic Acid) Scaffolds.

Authors:  Amanda Clark; J Zach Hilt; Todd A Milbrandt; David A Puleo
Journal:  Biores Open Access       Date:  2015-01-01

9.  Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity.

Authors:  John B Lees-Shepard; Sarah-Anne E Nicholas; Sean J Stoessel; Parvathi M Devarakonda; Michael J Schneider; Masakazu Yamamoto; David J Goldhamer
Journal:  Elife       Date:  2018-09-18       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.